47^th EDTNA/ERCA International Conference

September 15 - 18, 2018
Genoa, Italy
Booth #21

Symposium: Update from the DOPPS Program: Improving care, outcomes, and the patient experience
Sunday, September 16, 2018: 12:45 PM - 1:45 PM
Grecale Room

Topics and Speakers:

• DOPPS: Key hemodialysis practice changes and their impact – Loreto Gesualdo
• PDOPPS: New insights into optimal PD practice – Jen King
• CKDopps: Opportunities to improve care now for patients with advanced CKD – Solène Laville
• Empowering patients: Understanding and improving patient-provider connections – Marisa Pegoraro

Japanese Society for Dialysis Therapy (JSDT)

June 28 - July 1, 2018
Kobe, Japan

DOPPS Symposium: Sunday, July 1 at 8:20 a.m.

Chairpersons: Masafumi Fukagawa and Masaomi Nangaku
Speakers:

• Masaaki Inaba
• Kousaku Nitta
• Bruce Robinson
• Junichi Hosino
• Suguru Yamamoto
• Tadao Akizawa

PDOPPS Symposium: Sunday, July 1 at 10:20 a.m.

Chairpersons: Hideki Kawanishi and Bruce Robinson
Speakers:

• Bruce Robinson
• Hideki Kawanishi
• Yasuhiko Ito
• Mizuya Fukasawa
• Tadashi Tomo

European Renal Association / European Dialysis and Transplant Association (ERA-EDTA)

May 24-27, 2018
Copenhagen, Denmark
Booth #2.162

DOPPS Program Clinical Symposium
The sweet truth: Optimizing care in advanced CKD and dialysis with a focus on diabetic patients
Friday, May 25, 11:45 a.m. – 1:15 p.m., Room C1-M1-2

Chairpersons: Helmut Reichel and Bruce Robinson

Topics and Speakers:

• DOPPS Program: The burden of diabetes in advanced CKD and dialysis - Bruce Robinson
• PDOPPS: Variation in the PD prescription, glucose exposure, and outcomes - Mark Lambie
• DOPPS: Hepatitis C in HD patients - prevalence trends over 20 years, outcomes, and use of newer treatments - Michel Jadoul
• CKDopps: Diabetes treatment, control, and hypoglycemia in patients with advanced CKD - Benedicte Stengel
• EURODOPPS: Outcomes according to different strategies of HbA1c use among diabetic HD patients - Ionut Nistor

Poster Presentations

Friday, May 25

• Changes in practice patterns in Japan from before to after JSDT 2013 guidelines on hemodialysis prescriptions (Poster #FP638)
• CKD progression in Germany (Poster #FP346)
• International variation in MBD measurement, vitamin D prescription, and phosphate binder prescription patterns among patients with chronic kidney disease (Poster #FP386)
• Patient-reported disadvantages of peritoneal dialysis: Results from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) (Poster #FP483)
• Satisfaction, convenience, and difficulties in taking phosphate binders: Relationships with phosphate binder adherence in hemodialysis patients in the DOPPS (Poster #FP610)

Saturday, May 26

• Association between dipeptidyl peptidase-4 inhibitor prescription and erythropoiesis stimulating agent hyporesponsiveness in hemodialysis patients with diabetes mellitus (Poster #SP345)
• Indoxyl sulfate and mortality in hemodialysis patients: Results from the Japan Dialysis Outcomes and Practice Patterns Study (J-DOPPS) (Poster #SP617)
• Is low hemoglobin at hemodialysis initiation associated with first-year survival among patients treated to target levels soon after dialysis start? (Poster #SP340)
• Remote management for peritoneal dialysis: Perspectives on effects on care (Poster #SP502)
• The association of functional status with mortality and dialysis modality change: Results from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) (Poster #SP532)

National Kidney Foundation 2018 Spring Clinical Meetings

April 10-14, 2018
Austin, TX

American Society of Nephrology Kidney Week 2017

October 31 - November 5, 2017
New Orleans, LA

Oral Presentations

• Are RAASi underused in moderate to advanced CKD? Early findings from CKDopps
• Contemporary anemia management in peritoneal dialysis patients: Results from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS)  
• Low serum potassium is associated with indicators of under-nutrition and reduced residual kidney function: Results from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS)

Residual urine volume in hemodialysis patients: International trends, predictors and outcomes in the DOPPS		Functional status among patients receiving peritoneal dialysis: Results from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS)		Patient-reported advantages and disadvantages of peritoneal dialysis: Results from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS)
Mineral bone disorder management in dialysis patients: Comparing PTH control practices in Japan with Europe and North America in the DOPPS		Evaluation of gender differences in the association between hemoglobin and survival among hemodialysis patients in the JDOPPS		FGF23 and mortality in a large cohort of prevalent hemodialysis patients: Results from the JDOPPS

• Current nephrology practices for slowing CKD progression - The Chronic Kidney Disease Outcomes and Practice Patterns Study (CKDopps)
• International serum 25-OH-vitamin D measurement, levels, and treatment among patients with chronic kidney disease (CKD) in everyday nephrology practice: Results from CKDopps
• Mineral and bone disorder (MBD) markers and management over the first 5 years after dialysis start: Results from the DOPPS
• Engaging stakeholders in protocol development for qualitative research on remote management for peritoneal dialysis

46th EDTNA/ERCA International Conference

September 9 -12, 2017
Krakow, Poland

Symposium: The DOPPS Program Continues to Grow
Sunday, September 10, 2017: 12:45 PM - 1:45 PM
Theater Hall

Topics and Speakers:

• Key hemodialysis practice changes and their impact – Andrzej Wiecek
• PDOPPS: Identifying optimal practices in PD – Jen King
• CKDopps: Improving outcomes in advanced CKD and the transition to dialysis – Elodie Speyer
• “Ask your patients and do something about it”: The patient perspective in DOPPS – Jeanette Wallin

Japanese Society for Dialysis Therapy (JSDT)

June 16-18, 2017

Yokohama, Japan

DOPPS/ PDOPPS Symposium

June 18, 2017

DOPPS Presentation begins at 8:20 a.m.

PDOPPS presentation begins at 10:20 a.m.

European Renal Association / European Dialysis and Transplant Association (ERA-EDTA)

June 3-6, 2017

Madrid, Spain

Symposium: Optimizing care in advanced CKD and the transition to dialysis: Insights from DOPPS Program

June 5, 2017 at 3:15 p.m. 

Session number S 37, Hall 10

Topics and Speakers:

• The DOPPS Program: invitation to collaborators - Hugh Rayner
• CKDopps: Improving outcomes in advanced CKD and the transition to dialysis - Helmut Reichel
• DOPPS: Impact of clinical practices on early mortality among HD patients - Takeshi Hasegawa
• PDOPPS: Predictors of early successful PD use - Martin Wilkie
• Recent results from the EURODOPPS - Ayesha Sajjad

Free Communications

Sunday, June 4

• Cinacalcet discontinuation and its predictors in hemodialysis patients: Results from 7 European countries (#SO034). Session: CKD-MBD in dialysis (3:15 p.m.)
• Regional variation in mineral and bone disorder (MBD) markers and treatment at dialysis start: Results from the DOPPS (#SO032). Session: CKD-MBD in dialysis (3:15 p.m.)
• Dialysate calcium concentration <3.0mEq/L is not associated with improved outcomes in the Japan DOPPS (#SO061). Session: Epidemiology in dialysis – 2 (5:00-6:30 p.m.)

Monday, June 5

• International differences in time from arteriovenous fistula (AVF) creation until becoming catheter-free among HD patients using a catheter at time of AVF creation: Results from the DOPPS (#MO047). Session: Vascular Access (3:15 p.m.)
• Early Peritoneal Dialysis Attrition: Preliminary Results from The Peritoneal DOPPS (#MO061). Session: Peritoneal dialysis (5:00 p.m.)

Posters

Sunday, June 4, 9:30-10:45 a.m.

• Associations of coping strategies with quality of life, depression and mortality among hemodialysis patients in the DOPPS (#SP623)
• Hypokalemia in the Peritoneal Dialysis and Outcome Practice Patterns Study (PDOPPS): International variability and clinical predictors (#SP498)
• International variation in PD catheter practices: Preliminary results from the Peritoneal DOPPS (#SP503)
• Renin-angiotensin-aldosterone system inhibitors (RAASi) and clinical outcomes in hemodialysis patients: Results from the DOPPS (#SP551)
• Treatments of mineral and bone disorder may be under-utilized in CKD patients (#SP369)

Monday, June 5, 9:30-10:45 a.m.

• Prevalence of hyperkalemia in DOPPS: A real-world, international cohort of hemodialysis patients (#MP371)
• Renin-angiotensin-aldosterone system inhibitor prescription patterns in hemodialysis patients: Results from the International DOPPS (#MP385)
• Variation in Renin Angiotensin Aldosterone System Inhibitor (RAASi) prescription internationally and across CKD stages (#MP409)

• Regional Differences in the Associations between Prescribed Dialysate Sodium Concentration and Interdialytic Weight Gain in the DOPPS: A Call for Quality Assurance? (#MP704)

   

American Society of Nephrology Kidney Week 2016

November 15-20, 2016
Chicago, IL

Featured Posters

International variation in dialysis discontinuation: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS) (Abstract #TH-PO1108)		Association between diuretic use and residual kidney function in peritoneal dialysis patients: International comparison from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) (Abstract #SA-PO1102)